查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2094401

元基因組定序市場－2026-2032年全球市場預測

Metagenomic Sequencing Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，元基因組定序市場將成長至 66.5 億美元，複合年成長率為 14.15%。

主要市場統計數據
基準年 2025 26.3億美元
預計年份：2026年 29.9億美元
預測年份 2032 66.5億美元
複合年成長率 (%) 14.15%

元基因組定序正在改變微生物組研究、感染疾病監測、抗生素抗藥性監測、環境基因組學、食品安全、農業和生物製造等領域，它能夠以非培養的方式直接從複雜樣本中提取遺傳物質進行分析。與檢測預定義微生物的標靶檢測不同，鳥槍法元基因組定序和新一代元基因組次世代定序可以在單一工作流程中識別細菌、病毒、真菌、古菌、寄生蟲、功能基因、致病性標記和抗藥性決定因素。定序成本的降低、高通量儀器的出現、可攜式定序平台的普及、更全面的參考資料資料庫的建立以及生物資訊流程的改進，進一步推動了這一領域的發展，使大規模序列讀段能夠轉化為具有臨床和實際意義的見解。病原體基因組學、污水監測、「同一健康」計畫、醫院感染控制和食源性集體爆發調查等公共衛生重點領域也在推動宏基因組定序的需求。隨著應用範圍的擴大，相關人員越來越關注分析驗證、污染控制、樣品製備一致性、資料互通性、法規遵循、隱私保護和可重複解釋，以確保元基因組定序在研究、診斷和工業應用的所有領域都能提供可靠的價值。

元基因組定序領域的變革性變化

隨著元基因組定序技術從以研究為中心的應用轉向在醫療保健、環境監測、農業和公共衛生等領域提供可操作的決策支持，該領域正經歷著變革性的轉變。臨床微生物檢查室擴大評估宏基因組二代定序技術，以輔助複雜感染疾病的診斷，尤其是在傳統培養方法無效、結果獲取耗時或受既往元基因組次世代定序限制的情況下。公共衛生機構正在拓展其在基因組流行病學方面的能力，基於廢水的監測已展現出其在追蹤病毒病原體、抗生素抗藥性徵兆和社區健康趨勢方面的效用。在農業和食品系統中，總體基因體學正被擴大用於評估土壤微生物生態系統、動物健康、發酵品質、污染風險和供應鏈安全。從技術角度來看，長讀長定定序正在改進組裝、菌株鑑定、質體分析和抗生素抗藥性基因的背景分析，而短讀長定序在分析深度、成本效益和成熟的分析流程方面仍然具有價值。基於雲端的生物資訊學、標準化的報告格式、實驗室自動化和整合品管降低了應用門檻。然而，挑戰依然存在，包括宿主DNA去除、低生質能污染、資料庫偏差、意外觀察的解讀，以及跨實驗室和跨司法管轄區統一標準的必要性。

人工智慧對元基因組定序的累積影響

人工智慧透過改善訊號檢測、分類、功能註釋、集體爆發叢集、抗生素抗藥性預測和工作流程自動化，加速了元基因組定序的實際應用。機器學習技術有助於區分真正的微生物特徵和背景污染，優先篩選具有臨床意義的微生物，並識別高維多體學資料集中的模式。人工智慧驅動的流程正被擴大用於縮短分析時間、支援即時監測儀錶板、提高序列讀取分類的準確性，並將元基因組數據與流行病學、臨床、環境和地理空間資訊整合。在抗生素抗藥性監測中，基於精心整理的資料庫和檢驗的訓練集的預測模型可以更有效地關聯抗藥性基因、移動遺傳元件和宿主生物體。在環境和工業微生物學領域，人工智慧可用於闡明影響土壤生產力、污水處理性能、發酵穩定性和生態系統健康的微生物群落動態。人工智慧的累積影響取決於透明的模型檢驗、高品質的參考資料集、偏差緩解、可解釋的輸出、網路安全措施以及確保負責任使用的管治框架。將可靠的實驗室方法與人工智慧驅動的分析相結合的機構，更有能力將原始序列讀數轉化為可操作的微生物資訊。

區域層面關於全球元基因組定序應用的重要見解。

亞太地區正迅速崛起為元基因組定序領域一個充滿活力的區域，這主要得益於基因組分析基礎設施的不斷完善、國家精準醫療計劃的推進、感染疾病監測優先級的提升以及主要經濟體對生物技術投資的持續成長。該地區的宏基因組定序應用範圍廣泛，涵蓋醫院診斷、微生物組研究、水產養殖、農業、食品安全和環境監測等領域，其中人口稠密的都市區和生物多樣性豐富的生態系統對微生物資訊的需求尤為旺盛。在歐洲，合作研究框架、跨境病原體監測、嚴格的品質要求以及積極的微生物組和「同一健康」舉措，都為區域內宏基因組測序的協調、數據保護和標準化做出了貢獻。北美地區在先進的定序能力、強大的學術和公共衛生基因組學網路、抗微生物抗藥性工作、污水監測計劃以及完善的轉化研究基礎設施的支持下，宏基因組測序的應用日趨成熟。在拉丁美洲，元基因組定序在感染疾病監測、熱帶病研究、生物多樣性研究、農業生產力提升和食源性病原體監測等領域的應用日益廣泛，但檢查室能力的差異和資金籌措的不穩定性可能會阻礙其更深入的應用。在非洲，宏基因元基因組為集體爆發檢測、抗生素抗藥性監測、通用感染疾病監測、生物多樣性研究和污水流行病學提供了重要機遇，但能力建設、定序取得、人力資源開發和數據基礎設施對於永續定序仍然至關重要。在中東，基因組學和公共衛生正透過國家醫療衛生轉型計畫、感染疾病防範、糧食安全措施以及乾旱生態系統環境監測等手段實現現代化。

來自影響元基因組定序優先事項的關鍵群體的見解

北約成員國日益重視生物安全、生物監測、病原體檢測、軍事健康保護和韌性公共衛生基礎設施，而元基因組定序在緊急準備、快速反應和跨境風險評估中發揮著至關重要的作用。七國集團（G7）國家普遍擁有先進的定序基礎設施、強大的監管夥伴關係、高水準的研究活動，並在將元基因組數據整合到公共衛生、臨床微生物學、抗菌素抗藥性監測和環境監測等領域取得了顯著進展。歐盟正在建立一個系統化的元基因組定序應用環境，涵蓋醫學、農業和環境科學領域，重點在於協調研究經費、建立跨境數據共用框架、開展臨床檢驗、構建注重隱私的基因組數據管治以及推進「同一健康」監測。在金磚國家，總體基因體學在包括大規模公共衛生系統、新興生物技術產業、農業、污水監測和感染疾病監測在內的廣泛領域都被認為至關重要，儘管各國的基礎設施成熟度存在差異。在東協地區，元基因組定序的引入與感染疾病監測、食品安全、水產養殖、農業韌性以及熱帶生物多樣性研究密切相關，區域間合作在病原體監測和抗生素抗藥性追蹤方面的重要性日益凸顯。海灣合作理事會（GCC）成員國正積極將基因組學融入醫療衛生現代化、國家實驗室建設、環境監測、食品安全和感染疾病防治等領域，這主要得益於對數位醫療和先進診斷技術的濃厚興趣。

主要國家元基因組定序發展趨勢

美國是元基因組定序創新中心，積極參與臨床總體基因體學、污水監測、抗菌素抗藥性監測、微生物組學和公共衛生基因組學等領域。中國正迅速擴展其定序基礎設施，並將總體基因體學應用於感染疾病監測、農業、環境監測、醫院研究和微生物組學等領域。德國擁有強大的實驗室和工程能力，積極進行生物醫學研究、工業生物技術、抗菌素抗藥性計畫和環境微生物組學研究。日本專注於精準醫療、微生物組學、食品安全、環境基因組學和先進的定序流程。印度正在加強其基因組學網路，以服務公共衛生、抗菌素抗藥性追蹤、廢水監測、農業和感染疾病研究。英國將卓越的基因組學專業知識與公共衛生、臨床微生物學研究和污水監測所需的定序基礎設施相結合。法國強調感染疾病研究、食品安全、微生物組學和「同一健康」監測，而加拿大則專注於感染疾病監測、北極和環境微生物組學研究、食品安全以及綜合公共衛生檢測能力。義大利和西班牙正在推動元基因組分析在臨床研究、食品系統、環境監測和微生物組研究的應用。澳洲正在將元基因組定序應用於生物安全、環境監測、農業、公共衛生和海洋生態系統，而韓國在臨床研究、感染疾病控制、生物技術和數位健康整合方面擁有強大的實力。巴西擁有龐大的人口基數和豐富的生態系統多樣性，在熱帶病基因組學、生物多樣性、農業、污水流行病學和抗菌素抗藥性監測方面發揮著至關重要的作用。墨西哥正在將總體基因體學應用於食源性病原體、農業系統、微生物組研究和感染疾病研究，並看到了加強其檢查室網路所帶來的機會。俄羅斯正在利用定序進行感染疾病監測、環境研究、農業和公共衛生緊急準備。

為元基因組定序領域的領導者提供的實用建議

產業領導者應優先考慮檢驗的端到端宏基因元基因組，該流程應整合最佳化的檢體採集、核酸定序、根據需要定序宿主成分、樣品製備、定序、生物資訊分析和結果解讀報告。建立嚴格的品管至關重要，尤其對於低生物量檢體而言，污染會嚴重影響結果。各機構應投資建立精心整理的參考資料資料庫、透明的分析流程和可重複的報告標準，以贏得臨床醫生、監管機構、公共衛生負責人和產業使用者的信任。與醫院、公共衛生實驗室、農業組織、環境部門和學術機構建立策略夥伴關係，可以加速實際應用檢驗並擴展應用範圍。領導者還應負責任地建立人工智慧能力，利用檢驗的資料集、可解釋的模型以及在關鍵決策中採用「人機協作」的審查機制。資料管治必須涵蓋隱私、網路安全、知情同意、跨境資料傳輸和倫理考量，尤其是涉及人類宿主讀取資料或敏感集體爆發資料時。培養生物資訊學、分子微生物學、品管和法規科學領域的人才至關重要。最後，各組織應設計靈活的工作流程，以支援日常監測和對集體爆發、污染事件或新出現的病原體威脅的快速反應。

利用元基因組定序獲取見解的調查方法

本執行摘要採用系統的二手研究方法檢驗，參考了經驗證的科學、監管、公共衛生和行業相關資訊來源，包括同行評審文獻、公共衛生機構出版刊物、基因組監測指南、抗菌素抗藥性報告、污水監測文件、標準相關材料以及公開的政策文件。研究途徑調查方法強調跨多個可靠資訊來源進行檢驗，以評估元基因組定序的技術採納模式、應用案例成熟度、區域優先事項、人工智慧整合以及操作障礙。證據評估涵蓋醫療保健、環境、農業、食品安全和公共衛生等領域，並檢視其相關性、時效性、科學可靠性和適用性。本分析排除了未經證實的說法，也不涉及市場規模、市場佔有率或預測。研究結果圍繞著技術促進因素、採納挑戰、區域擴散趨勢以及對決策者的策略意義。尤其強調檢驗要求、定序工作流程品質、生物資訊學可重複性、參考資料資料庫的限制、資料管治以及在實際環境中部署的注意事項。

結論：元基因組定序作為一種策略性微生物情報平台

元基因組定序正逐漸成為一種無需培養的微生物分析基礎技術，它能夠更廣泛地檢測微生物，加快調查速度，並加深對醫療保健、公共衛生、農業、食品安全和環境系統的功能理解。當需要高解析度地評估複雜的微生物群落、不可培養的微生物、抗生素抗藥性、集體爆發徵兆或生態系統層面的相互作用時，其價值尤其顯著。人工智慧、長讀長和短讀長定定序的整合、實驗室自動化、雲端生物資訊學以及標準化的監測框架正在提升宏基因組定序的易用性和擴充性。同時，檢驗的方法、污染控制、高品質的參考資料資料庫、專業的解讀以及負責任的資料管治對於成功至關重要。擁有強大的基因組基礎設施、互聯互通的公共衛生系統和跨學科合作的地區和國家，最有能力將元基因組數據轉化為可操作的見解。隨著宏基因組定序應用範圍的擴大，那些專注於分析可靠性、透明報告、合規性和可操作決策支援的產業領導者，將最有能力充分釋放元基因組定序的潛力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：元基因組定序市場：依產品類型分類

  • 生物資訊學和分析工具
    • 數據分析軟體
    • 資料管理和儲存解決方案
    • 分析工具
  • 耗材和工具包
    • 益智套裝
    • 樣品製備工具包
    • 試劑
    • 定序盒
  • 裝置
  • 服務
    • 客製化檢測服務
    • 數據分析服務
    • 定序服務

第8章：元基因組定序市場：依樣本類型分類

  • 農業樣品
    • 植物組織
    • 土壤
  • 臨床檢體
    • 血
    • 航班
    • 組織
  • 環境樣品
    • 空氣
    • 土壤
    • 水
  • 食品樣品
    • 乳製品
    • 肉類/家禽
    • 農產品

第9章：元基因組定序市場：依技術分類

  • 長讀長定定序
  • 短讀定序

第10章：元基因組定序市場：依通量分類

  • 低通量定序
  • 高通量定序
  • 中等通量定序

第11章：元基因組定序市場：依應用領域分類

  • 學術研究
  • 臨床診斷
    • 遺傳疾病的檢測
    • 感染疾病分析
    • 微生物組分析
    • 腫瘤學調查
  • 環境調查
  • 食品和農業檢驗
    • 病原體檢測
    • 品質監控
    • 土壤健康評估

第12章：元基因組定序市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章：元基因組定序市場：依組別分類

  • NATO
  • G7
  • EU
  • BRICS
  • ASEAN
  • GCC

第14章：元基因組定序市場：依國家分類

  • 美國
  • 中國
  • 德國
  • 日本
  • 印度
  • 英國
  • 法國
  • 加拿大
  • 義大利
  • 澳洲
  • 韓國
  • 巴西
  • 墨西哥
  • 俄羅斯
  • 西班牙

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • BGI Group Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • Complete Genomics, Inc.
  • Danaher Corporation
  • Eurofins Scientific SE
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Macrogen, Inc.
  • Merck KGaA
  • MGI Tech Co., Ltd.
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Revvity, Inc.
  • Roche Holding AG
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Zymo Research Corp.
Product Code: MRR-E3708867678B

The Metagenomic Sequencing Market is projected to grow by USD 6.65 billion at a CAGR of 14.15% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.63 billion
Estimated Year [2026] USD 2.99 billion
Forecast Year [2032] USD 6.65 billion
CAGR (%) 14.15%

Metagenomic sequencing is reshaping microbiome research, infectious disease surveillance, antimicrobial resistance monitoring, environmental genomics, food safety, agriculture, and biomanufacturing by enabling culture-independent analysis of genetic material recovered directly from complex samples. Unlike targeted assays that detect predefined organisms, shotgun metagenomic sequencing and metagenomic next-generation sequencing can characterize bacteria, viruses, fungi, archaea, parasites, functional genes, virulence markers, and resistance determinants in a single workflow. The field is being strengthened by lower sequencing costs, higher-throughput instruments, portable sequencing platforms, richer reference databases, and improved bioinformatics pipelines that convert large-scale sequence reads into clinically and operationally meaningful insights. Demand is also supported by public health priorities such as pathogen genomics, wastewater surveillance, One Health programs, hospital infection control, and foodborne outbreak investigation. As adoption expands, stakeholders are increasingly focused on analytical validation, contamination control, sample preparation consistency, data interoperability, regulatory readiness, privacy safeguards, and reproducible interpretation to ensure that metagenomic sequencing delivers reliable value across research, diagnostics, and industrial applications.

Transformative Shifts in the Metagenomic Sequencing Landscape

The metagenomic sequencing landscape is undergoing transformative shifts as the technology moves from research-centered use toward applied decision-making in healthcare, environmental monitoring, agriculture, and public health. Clinical microbiology laboratories are evaluating metagenomic next-generation sequencing to support diagnosis of complex infections, particularly when conventional culture is negative, slow, or limited by prior antimicrobial exposure. Public health agencies are expanding genomic epidemiology capabilities, with wastewater-based surveillance demonstrating utility for tracking viral pathogens, antimicrobial resistance signals, and community-level health trends. In agriculture and food systems, metagenomics is increasingly used to assess soil microbial ecology, animal health, fermentation quality, contamination risks, and supply chain safety. At the technology level, long-read sequencing is improving assembly, strain resolution, plasmid analysis, and antimicrobial resistance gene context, while short-read sequencing remains valuable for depth, cost efficiency, and established analytical workflows. Cloud-based bioinformatics, standardized reporting formats, laboratory automation, and integrated quality control are reducing barriers to adoption. However, persistent challenges remain, including host DNA depletion, low-biomass contamination, database bias, interpretation of incidental findings, and the need for harmonized standards across laboratories and jurisdictions.

Cumulative Impact of Artificial Intelligence on Metagenomic Sequencing

Artificial intelligence is accelerating the practical utility of metagenomic sequencing by improving signal detection, taxonomic classification, functional annotation, outbreak clustering, antimicrobial resistance prediction, and workflow automation. Machine learning methods can help distinguish true microbial signatures from background contamination, prioritize clinically relevant organisms, and identify patterns across high-dimensional multi-omics datasets. AI-enabled pipelines are increasingly used to compress analysis timelines, support real-time surveillance dashboards, improve sequence read classification, and integrate metagenomic data with epidemiological, clinical, environmental, and geospatial information. In antimicrobial resistance monitoring, predictive models can link resistance genes, mobile genetic elements, and host organisms more effectively when supported by curated databases and validated training sets. In environmental and industrial microbiology, AI can reveal community dynamics that influence soil productivity, wastewater treatment performance, fermentation stability, and ecosystem health. The cumulative impact of AI will depend on transparent model validation, high-quality reference datasets, bias mitigation, explainable outputs, cybersecurity controls, and governance frameworks that ensure responsible use. Organizations that combine robust laboratory methods with AI-driven analytics are better positioned to transform raw sequencing reads into actionable microbial intelligence.

Key Regional Insights Across Global Metagenomic Sequencing Adoption

Asia-Pacific is emerging as a highly dynamic region for metagenomic sequencing due to expanding genomics infrastructure, national precision medicine programs, infectious disease surveillance priorities, and growing investment in biotechnology across major economies. Regional use cases span hospital diagnostics, microbiome research, aquaculture, agriculture, food safety, and environmental monitoring, with dense urban populations and biodiversity-rich ecosystems creating strong demand for microbial intelligence. Europe benefits from coordinated research frameworks, cross-border pathogen surveillance, stringent quality requirements, and active microbiome and One Health initiatives, making harmonization, data protection, and standardization central to regional adoption. North America demonstrates mature adoption supported by advanced sequencing capacity, strong academic and public health genomics networks, antimicrobial resistance initiatives, wastewater surveillance programs, and established translational research infrastructure. Latin America is increasingly applying metagenomic sequencing to infectious disease surveillance, tropical disease research, biodiversity studies, agricultural productivity, and foodborne pathogen monitoring, although uneven laboratory capacity and funding variability can influence implementation depth. Africa presents critical opportunities for metagenomic sequencing in outbreak detection, antimicrobial resistance surveillance, zoonotic disease monitoring, biodiversity research, and wastewater epidemiology, while capacity building, sequencing accessibility, workforce development, and data infrastructure remain essential for sustainable deployment. The Middle East is advancing genomics and public health modernization through national healthcare transformation programs, infectious disease preparedness, food security initiatives, and environmental monitoring in arid ecosystems.

Key Group Insights Shaping Metagenomic Sequencing Priorities

NATO member states place growing emphasis on biosecurity, biosurveillance, pathogen detection, military health protection, and resilient public health infrastructure, making metagenomic sequencing relevant for preparedness, rapid response, and cross-border risk assessment. G7 countries generally demonstrate advanced sequencing infrastructure, strong regulatory engagement, high research intensity, and increasing integration of metagenomic data into public health, clinical microbiology, antimicrobial resistance monitoring, and environmental surveillance. The European Union emphasizes coordinated research funding, cross-border data sharing frameworks, clinical validation, privacy-compliant genomic data governance, and One Health surveillance, creating a structured environment for metagenomic sequencing applications in healthcare, agriculture, and environmental science. BRICS economies show broad relevance for metagenomics across large population health systems, emerging biotechnology sectors, agriculture, wastewater monitoring, and infectious disease surveillance, although infrastructure maturity differs by country. Within ASEAN, metagenomic sequencing adoption is closely linked to infectious disease monitoring, food safety, aquaculture, agricultural resilience, and tropical biodiversity research, with regional collaboration becoming increasingly important for pathogen surveillance and antimicrobial resistance tracking. GCC countries are integrating genomics into healthcare modernization, national laboratory development, environmental surveillance, food security, and infectious disease preparedness, supported by strong interest in digital health and advanced diagnostics.

Key Country Insights for Metagenomic Sequencing Development

The United States is a central hub for metagenomic sequencing innovation, with strong activity in clinical metagenomics, wastewater surveillance, antimicrobial resistance monitoring, microbiome science, and public health genomics. China has rapidly expanded sequencing infrastructure and applies metagenomics across infectious disease surveillance, agriculture, environmental monitoring, hospital research, and microbiome science. Germany is active in biomedical research, industrial biotechnology, antimicrobial resistance programs, and environmental microbiome studies, supported by strong laboratory and engineering capacity. Japan focuses on precision health, microbiome science, food safety, environmental genomics, and advanced sequencing workflows. India is strengthening genomics networks for public health, antimicrobial resistance tracking, wastewater surveillance, agriculture, and infectious disease research. The United Kingdom combines strong genomics expertise with public health sequencing infrastructure, clinical microbiology research, and wastewater monitoring capabilities. France emphasizes infectious disease research, food safety, microbiome science, and One Health surveillance, while Canada emphasizes infectious disease surveillance, Arctic and environmental microbiome research, food safety, and integrated public health laboratory capabilities. Italy and Spain are advancing metagenomic applications in clinical research, food systems, environmental surveillance, and microbiome studies. Australia applies metagenomic sequencing to biosecurity, environmental monitoring, agriculture, public health, and marine ecosystems, while South Korea demonstrates strong capacity in clinical research, infectious disease preparedness, biotechnology, and digital health integration. Brazil has significant relevance in tropical disease genomics, biodiversity, agriculture, wastewater epidemiology, and antimicrobial resistance surveillance due to its large population base and ecological diversity. Mexico is applying metagenomics to foodborne pathogens, agricultural systems, microbiome research, and infectious disease studies, with opportunities tied to laboratory network strengthening. Russia applies sequencing to infectious disease monitoring, environmental research, agriculture, and public health preparedness.

Actionable Recommendations for Metagenomic Sequencing Leaders

Industry leaders should prioritize validated, end-to-end metagenomic sequencing workflows that integrate optimized sample collection, nucleic acid extraction, host depletion where appropriate, library preparation, sequencing, bioinformatics, and interpretive reporting. Establishing rigorous quality control is essential, particularly for low-biomass samples where contamination can distort findings. Organizations should invest in curated reference databases, transparent analytical pipelines, and reproducible reporting standards to improve confidence among clinicians, regulators, public health officials, and industrial users. Strategic partnerships with hospitals, public health laboratories, agricultural agencies, environmental authorities, and academic groups can accelerate real-world validation and broaden application pathways. Leaders should also build AI capabilities responsibly by using validated datasets, explainable models, and human-in-the-loop review for high-consequence decisions. Data governance must address privacy, cybersecurity, consent, cross-border data transfer, and ethical considerations, especially when human host reads or sensitive outbreak data are involved. Workforce development in bioinformatics, molecular microbiology, quality management, and regulatory science will be critical. Finally, organizations should design flexible workflows that can support both routine surveillance and rapid response during outbreaks, contamination events, or emerging pathogen threats.

Research Methodology for Metagenomic Sequencing Insights

This executive summary is developed through a structured secondary research approach using verified scientific, regulatory, public health, and industry-relevant sources, including peer-reviewed literature, public health agency publications, genomic surveillance guidance, antimicrobial resistance reports, wastewater surveillance documentation, standards-oriented materials, and publicly available policy resources. The methodology emphasizes triangulation across multiple credible sources to assess technology adoption patterns, use-case maturity, regional priorities, AI integration, and operational barriers in metagenomic sequencing. Evidence is evaluated for relevance, recency, scientific reliability, and applicability across healthcare, environmental, agricultural, food safety, and public health contexts. The analysis excludes unsupported claims and avoids market sizing, market share, and forecasting. Insights are organized to reflect technology drivers, implementation challenges, geographic adoption dynamics, and strategic implications for decision-makers. Particular attention is given to validation requirements, sequencing workflow quality, bioinformatics reproducibility, reference database limitations, data governance, and real-world deployment considerations.

Conclusion: Metagenomic Sequencing as a Strategic Microbial Intelligence Platform

Metagenomic sequencing is becoming a foundational technology for culture-independent microbial analysis, enabling broader detection, faster investigation, and deeper functional understanding across healthcare, public health, agriculture, food safety, and environmental systems. Its value is strongest where complex microbial communities, unculturable organisms, antimicrobial resistance, outbreak signals, or ecosystem-level interactions must be assessed with high resolution. Artificial intelligence, long-read and short-read sequencing integration, laboratory automation, cloud bioinformatics, and standardized surveillance frameworks are improving usability and scalability. At the same time, success depends on validated methods, contamination control, high-quality reference databases, skilled interpretation, and responsible data governance. Regions and countries with strong genomics infrastructure, coordinated public health systems, and interdisciplinary collaboration are best positioned to convert metagenomic data into actionable intelligence. As adoption broadens, industry leaders that focus on analytical reliability, transparent reporting, regulatory alignment, and practical decision support will be better equipped to unlock the full potential of metagenomic sequencing.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Metagenomic Sequencing Market, by Product Type

  • 7.1. Introduction
  • 7.2. Bioinformatics & Analysis Tools
    • 7.2.1. Data Analysis Software
    • 7.2.2. Data Management & Storage Solutions
    • 7.2.3. Interpretation Tools
  • 7.3. Consumables & Kits
    • 7.3.1. Enrichment Kits
    • 7.3.2. Library Preparation Kits
    • 7.3.3. Reagents
    • 7.3.4. Sequencing Kits
  • 7.4. Instruments
  • 7.5. Services
    • 7.5.1. Custom Assay Services
    • 7.5.2. Data Analysis Services
    • 7.5.3. Sequencing Services

8. Metagenomic Sequencing Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Agricultural Samples
    • 8.2.1. Plant Tissues
    • 8.2.2. Soil
  • 8.3. Clinical Samples
    • 8.3.1. Blood
    • 8.3.2. Stool
    • 8.3.3. Tissue
  • 8.4. Environmental Samples
    • 8.4.1. Air
    • 8.4.2. Soil
    • 8.4.3. Water
  • 8.5. Food Samples
    • 8.5.1. Dairy
    • 8.5.2. Meat & Poultry
    • 8.5.3. Produce

9. Metagenomic Sequencing Market, by Technology

  • 9.1. Introduction
  • 9.2. Long-Read Sequencing
  • 9.3. Short-Read Sequencing

10. Metagenomic Sequencing Market, by Throughput

  • 10.1. Introduction
  • 10.2. Low-throughput Sequencing
  • 10.3. High-throughput Sequencing
  • 10.4. Medium-throughput Sequencing

11. Metagenomic Sequencing Market, by Application

  • 11.1. Introduction
  • 11.2. Academic Research
  • 11.3. Clinical Diagnostics
    • 11.3.1. Genetic Disorder Detection
    • 11.3.2. Infectious Disease Profiling
    • 11.3.3. Microbiome Analysis
    • 11.3.4. Oncology Research
  • 11.4. Environmental Studies
  • 11.5. Food & Agriculture Testing
    • 11.5.1. Pathogen Detection
    • 11.5.2. Quality Monitoring
    • 11.5.3. Soil Health Assessment

12. Metagenomic Sequencing Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. Metagenomic Sequencing Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. ASEAN
  • 13.6. GCC

14. Metagenomic Sequencing Market, by Country

  • 14.1. United States
  • 14.2. China
  • 14.3. Germany
  • 14.4. Japan
  • 14.5. India
  • 14.6. United Kingdom
  • 14.7. France
  • 14.8. Canada
  • 14.9. Italy
  • 14.10. Australia
  • 14.11. South Korea
  • 14.12. Brazil
  • 14.13. Mexico
  • 14.14. Russia
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. 10x Genomics, Inc.
  • 16.2. Agilent Technologies, Inc.
  • 16.3. Azenta Life Sciences
  • 16.4. BGI Group Co., Ltd.
  • 16.5. Bio-Rad Laboratories, Inc.
  • 16.6. BioMerieux SA
  • 16.7. Complete Genomics, Inc.
  • 16.8. Danaher Corporation
  • 16.9. Eurofins Scientific SE
  • 16.10. Illumina, Inc.
  • 16.11. Integrated DNA Technologies, Inc.
  • 16.12. Macrogen, Inc.
  • 16.13. Merck KGaA
  • 16.14. MGI Tech Co., Ltd.
  • 16.15. Novogene Co., Ltd.
  • 16.16. Oxford Nanopore Technologies Ltd.
  • 16.17. Pacific Biosciences of California, Inc.
  • 16.18. Promega Corporation
  • 16.19. QIAGEN N.V.
  • 16.20. Revvity, Inc.
  • 16.21. Roche Holding AG
  • 16.22. Thermo Fisher Scientific Inc.
  • 16.23. Twist Bioscience Corporation
  • 16.24. Zymo Research Corp.

LIST OF FIGURES

  • FIGURE 1. GLOBAL METAGENOMIC SEQUENCING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL METAGENOMIC SEQUENCING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL METAGENOMIC SEQUENCING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL METAGENOMIC SEQUENCING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL METAGENOMIC SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL METAGENOMIC SEQUENCING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL METAGENOMIC SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOINFORMATICS & ANALYSIS TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOINFORMATICS & ANALYSIS TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOINFORMATICS & ANALYSIS TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DATA MANAGEMENT & STORAGE SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DATA MANAGEMENT & STORAGE SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DATA MANAGEMENT & STORAGE SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTERPRETATION TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTERPRETATION TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTERPRETATION TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONSUMABLES & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONSUMABLES & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONSUMABLES & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENRICHMENT KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENRICHMENT KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENRICHMENT KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LIBRARY PREPARATION KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIBRARY PREPARATION KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIBRARY PREPARATION KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SEQUENCING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SEQUENCING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SEQUENCING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CUSTOM ASSAY SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CUSTOM ASSAY SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CUSTOM ASSAY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SEQUENCING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AGRICULTURAL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AGRICULTURAL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AGRICULTURAL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PLANT TISSUES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PLANT TISSUES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PLANT TISSUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SOIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SOIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SOIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CLINICAL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CLINICAL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CLINICAL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STOOL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STOOL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STOOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENVIRONMENTAL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENVIRONMENTAL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENVIRONMENTAL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SOIL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SOIL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SOIL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL WATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL WATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FOOD SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FOOD SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FOOD SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DAIRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DAIRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DAIRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEAT & POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEAT & POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEAT & POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PRODUCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PRODUCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PRODUCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL LONG-READ SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL LONG-READ SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL LONG-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL LOW-THROUGHPUT SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL LOW-THROUGHPUT SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL LOW-THROUGHPUT SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HIGH-THROUGHPUT SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HIGH-THROUGHPUT SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HIGH-THROUGHPUT SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDIUM-THROUGHPUT SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDIUM-THROUGHPUT SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDIUM-THROUGHPUT SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GENETIC DISORDER DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GENETIC DISORDER DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL GENETIC DISORDER DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL INFECTIOUS DISEASE PROFILING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL INFECTIOUS DISEASE PROFILING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL INFECTIOUS DISEASE PROFILING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MICROBIOME ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MICROBIOME ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MICROBIOME ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ONCOLOGY RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ONCOLOGY RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ONCOLOGY RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ENVIRONMENTAL STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ENVIRONMENTAL STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ENVIRONMENTAL STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL FOOD & AGRICULTURE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL FOOD & AGRICULTURE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL FOOD & AGRICULTURE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PATHOGEN DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PATHOGEN DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PATHOGEN DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL QUALITY MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL QUALITY MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL QUALITY MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL SOIL HEALTH ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SOIL HEALTH ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL SOIL HEALTH ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 235. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 240. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 242. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 243. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 244. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 245. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 247. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 249. NATO METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 250. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 251. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 254. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 255. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 257. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 258. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 259. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 260. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 262. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 264. G7 METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 296. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 298. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 299. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 310. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 311. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 313. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 314. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 315. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 317. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 318. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 319. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 320. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 322. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 324. GCC METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 325. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD & AGRICULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 341. CHINA METAGENOMIC SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 342. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY BIOINFORMATICS & ANALYSIS TOOLS, 2018-2032 (USD MILLION)
  • TABLE 344. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY CONSUMABLES & KITS, 2018-2032 (USD MILLION)
  • TABLE 345. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 346. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY AGRICULTURAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 348. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 349. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 350. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY FOOD SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 351. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-203